Mina Fahim is the CEO and President of MediView XR, a Cleveland-based medical technology company giving clinicians a form of 3D 'X-ray vision' by fusing CT scans and live ultrasound into holograms surgeons can see through a headset. A University of Minnesota-trained biomedical engineer and former Medtronic research engineer, he helped steer MediView to the first FDA 510(k) clearance for an AR device that combines live imaging with 3D XR visualization (the XR90), a $24M Series A led by GE HealthCare, and the world's first-in-human AR tumor ablation at the Cleveland Clinic. His mantra: simplify, democratize, and inform care.

Thomas (Tom) Arnold is the Chief Executive Officer of ViCentra, the Dutch maker of Kaleido, billed as one of the smallest, lightest and most precise insulin patch pumps in its class. Appointed in February 2025 after nearly 25 years across Medtronic, PROCEPT BioRobotics, Boston Scientific and Sorin Group, he is steering ViCentra's smartphone-controlled automated insulin delivery system into European markets and toward a US entry, backed by financing that has grown from $85M to $98M.